Investigations

Search
Categories
Archives

Investment Monitoring From Robbins LLP

To ensure your financial investments are being managed honestly, enroll in Stock Watch, our free investment monitoring service for individual and institutional investors.

Aurora Cannabis, Inc.

Aurora Cannabis, Inc. (ACB) Accused of Failing to Disclose Sizable Impairment Charges   During the relevant period, Aurora Cannabis, Inc. failed to disclose that it had significantly overpaid for recently

Read More

Investigation of Golar LNG Limited

Golar LNG Limited (GLNG) Accused of Misleading Shareholders   On September 17, 2020, Golar announced the initial public offering of Hygo Energy Transition Ltd. (“Hygo”), a joint venture between Golar

Read More

Investigation of NextCure, Inc.

NextCure, Inc. (NXTC) Accused of Misleading Shareholders   During the class period, defendants misled investors regarding the efficacy of and objective responses observed in patients treated with NC318 from the

Read More

Investigation of Nikola Corporation

Nikola Corporation (NKLA) Accused of Misleading Shareholders  During the class period, Trevor Milton, chairman and founder, repeatedly falsely touted the strength of Nikola’s financial, technological, and operational profile. On September

Read More

Investigation of GoHealth, Inc.

GoHealth (GOCO) Accused of Misleading Shareholders In September 2019, private equity firm Centerbridge acquired GoHealth for $1.1 billion in equity and cash.  According to the complaint, GoHealth reported tremendous growth

Read More

Investigation of Nikola Corporation

Nikola Corporation (NKLA) Accused of Misleading Shareholders  During the class period, Trevor Milton, chairman and founder, repeatedly falsely touted the strength of Nikola’s financial, technological, and operational profile. On September

Read More

Investigation of Odonate Therapeutics, Inc.

Odonate Therapeutics, Inc. (ODT) Accused of Misrepresenting Potential of New Cancer Drug During the relevant period, Odonate Therapeutics, Inc. touted the extent of its clinical trials of tesetaxel and the

Read More
Skip to content